Sechenov University establishes the Institute of Bionic Technology and Engineering
26 March 2018
The Institute of Bionic Technology and Engineering was established in March 2018 at Sechenov University’s Biomedicine Science and Technology Park. The key objectives of the Institute include the development of artificial organs and bionic prostheses, hemocompatible anticoagulant coatings for implants, as well as tissue engineering, intelligent diagnostics, and organs on chips.
Russia officially joined the MEDICRIME Convention
26 March 2018
The Russian Minister of Health Veronika Skvortsova deposited the instrument of ratification of the Council of Europe Convention on the counterfeiting of medical products and similar crimes involving threats to public health (MEDICRIME Convention) with the Secretary General of the Council of Europe Thorbjørn Jagland.
Russian pharmacy market increased by 6.5% in ruble terms in 2017
23 March 2018
In 2017, 5065.8 million packages of drugs worth 940.7 billion rubles (in retail prices) were sold through the pharmacies in Russia. This is 6.5% higher than in 2016 in value terms and 3.5% higher in physical terms.
Russian pharma companies released the drugs worth 333.6 billion rubles in 2017
23 March 2018
For Russian pharmaceutical manufacturers, the overall results of 2017 were not impressive at all, to put it mildly. In total, last year, Russia manufactured about 4.5 billion packages of medicinal products, which is only 0.7% more than for 2016. The ruble-denominated figure for the same period looks better reaching 6.1%. However, it is still not even close to the pace demonstrated by the Russian pharmaceutical industry in 2015-2016.
GMP Inspection practice: a case for global benchmarking, convergence and mutual reliance/recognition
22 March 2018
In 1969 the global agreement on the Certification Scheme on the Quality of Pharmaceutical Products Moving in International Commerce was proposed by WHO. The aim was to facilitate international trade in pharmaceuticals through mutual recognition of GMP inspection results. Today, almost 50 years later, up to one hundred countries conduct foreign inspections. As a result a manufacturing site well established, might be inspected many times in one year by local and different foreign authorities. This leads to duplication of work and waste of recourses both by regulators and industry.
Kaluga is expected to complete its program for radiopharmaceuticals in two years
22 March 2018
Kaluga pharmaceutical cluster recently increased the number of locally manufactured drugs from 65 to 154. The Governor Anatoly Artamonov expects that the region needs 2 more years to complete its import substitution program for radiopharmaceuticals, reported Kaluzhskaya Nedelya, a local newspaper.
Blockchain technology has a special potential to confront counterfeit drugs
21 March 2018
DHL has released a trend report in cooperation with Accenture, a leading global technology consultant, on blockchain technology’s potential to transform the logistics industry. The report includes initial findings on a working prototype developed by DHL and Accenture, which tracks pharmaceuticals from the point of origin to the consumer, preventing tampering and errors.
Russia establishes its National Quality Infrastructure Council
20 March 2018
On March 14, Denis Manturov, the Russian Minister of Industry and Trade, chaired a meeting of the State Commission on Counteraction to Illegal Circulation of Industrial Products. The Minister said that, ensuring the “market purity” would require, in addition to providing more preferences for entrepreneurs operating strictly within the legal field, to guarantee to potential consumers that they purchase genuine rather than counterfeit and falsified products.
Researchers in aging tie genes to brain degeneration
20 March 2018
As brain cells age, they lose their ability to perform basic functions, often leading to dementia and other neurodegenerative disorders. But what’s behind this decline, and can it be stopped? Two new studies out this week uncover links between genes and brain-cell functioning that could provide new targets for therapies aimed at neurodegenerative diseases.
China established a new drug regulator
19 March 2018
After about five years as a standalone agency, the China Food and Drug Administration (CFDA) will merge into a gigantic national market supervision administration, with drug regulation as a new, second-tier bureau underneath.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Four cancer centers opened in Russia in 2023
26 April 2024
Russia and the UAE can simplify the drug registration process
26 April 2024
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024